L3VLUP
ProSign in
← Renaissance Technologies LLC, latest filing

What Renaissance Technologies LLC changed, 2013 to 2026

53 quarterly 13F filings, from Q2 2013 to Q2 2026, each read from the filing itself. A quarter is compared only with the quarter before it, so a quarter with no filing is a gap in the record, not a sale.

Reported book

$72.6bn

$38.1bn at Q2 2013

Positions

3,140

2,756 at Q2 2013

Top ten weight

12%

11% at Q2 2013

Typical quarterly turnover

about 22%

Estimated from share changes

Reported book by quarter
$0$65bn$130bnQ2 2013: $38.1bnQ3 2013: $41.2bnQ4 2013: $41.8bnQ1 2014: $41.7bn14Q2 2014: $42.9bnQ3 2014: $36.5bnQ4 2014: $41.4bnQ1 2015: $47.0bn15Q2 2015: $43.9bnQ3 2015: $41.9bnQ4 2015: $45.9bnQ1 2016: $52.6bn16Q2 2016: $52.5bnQ3 2016: $56.6bnQ4 2016: $63.2bnQ1 2017: $71.6bn17Q2 2017: $78.4bnQ3 2017: $85.0bnQ4 2017: $90.7bnQ1 2018: $91.4bn18Q2 2018: $91.7bnQ3 2018: $97.3bnQ4 2018: $91.3bnQ1 2019: $110bn19Q2 2019: $114bnQ3 2019: $118bnQ4 2019: $130bnQ1 2020: $103bn20Q2 2020: $116bnQ3 2020: $100bnQ4 2020: $92.1bnQ1 2021: $80.4bn21Q2 2021: $80.1bnQ3 2021: $77.4bnQ4 2021: $80.4bnQ1 2022: $85.2bn22Q2 2022: $84.5bnQ3 2022: $70.7bnQ4 2022: $73.1bnQ1 2023: $75.4bn23Q2 2023: $69.4bnQ3 2023: $58.7bnQ4 2023: $64.6bnQ1 2024: $63.6bn24Q2 2024: $59.0bnQ3 2024: $66.5bnQ4 2024: $67.6bnQ1 2025: $66.1bn25Q2 2025: $75.2bnQ3 2025: $75.8bnQ4 2025: $64.5bnQ1 2026: $63.9bn26Q2 2026: $72.6bn
  • Q2 2013: $38.1bn
  • Q3 2013: $41.2bn
  • Q4 2013: $41.8bn
  • Q1 2014: $41.7bn
  • Q2 2014: $42.9bn
  • Q3 2014: $36.5bn
  • Q4 2014: $41.4bn
  • Q1 2015: $47.0bn
  • Q2 2015: $43.9bn
  • Q3 2015: $41.9bn
  • Q4 2015: $45.9bn
  • Q1 2016: $52.6bn
  • Q2 2016: $52.5bn
  • Q3 2016: $56.6bn
  • Q4 2016: $63.2bn
  • Q1 2017: $71.6bn
  • Q2 2017: $78.4bn
  • Q3 2017: $85.0bn
  • Q4 2017: $90.7bn
  • Q1 2018: $91.4bn
  • Q2 2018: $91.7bn
  • Q3 2018: $97.3bn
  • Q4 2018: $91.3bn
  • Q1 2019: $110bn
  • Q2 2019: $114bn
  • Q3 2019: $118bn
  • Q4 2019: $130bn
  • Q1 2020: $103bn
  • Q2 2020: $116bn
  • Q3 2020: $100bn
  • Q4 2020: $92.1bn
  • Q1 2021: $80.4bn
  • Q2 2021: $80.1bn
  • Q3 2021: $77.4bn
  • Q4 2021: $80.4bn
  • Q1 2022: $85.2bn
  • Q2 2022: $84.5bn
  • Q3 2022: $70.7bn
  • Q4 2022: $73.1bn
  • Q1 2023: $75.4bn
  • Q2 2023: $69.4bn
  • Q3 2023: $58.7bn
  • Q4 2023: $64.6bn
  • Q1 2024: $63.6bn
  • Q2 2024: $59.0bn
  • Q3 2024: $66.5bn
  • Q4 2024: $67.6bn
  • Q1 2025: $66.1bn
  • Q2 2025: $75.2bn
  • Q3 2025: $75.8bn
  • Q4 2025: $64.5bn
  • Q1 2026: $63.9bn
  • Q2 2026: $72.6bn
Share of the book in the ten largest positions
0%8%15%Q2 2013: 11%Q3 2013: 11%Q4 2013: 11%Q1 2014: 13%14Q2 2014: 14%Q3 2014: 13%Q4 2014: 11%Q1 2015: 10%15Q2 2015: 10%Q3 2015: 10%Q4 2015: 9%Q1 2016: 8%16Q2 2016: 8%Q3 2016: 8%Q4 2016: 7%Q1 2017: 8%17Q2 2017: 9%Q3 2017: 9%Q4 2017: 8%Q1 2018: 9%18Q2 2018: 9%Q3 2018: 10%Q4 2018: 9%Q1 2019: 9%19Q2 2019: 9%Q3 2019: 11%Q4 2019: 13%Q1 2020: 15%20Q2 2020: 14%Q3 2020: 15%Q4 2020: 13%Q1 2021: 10%21Q2 2021: 12%Q3 2021: 12%Q4 2021: 12%Q1 2022: 12%22Q2 2022: 11%Q3 2022: 11%Q4 2022: 11%Q1 2023: 11%23Q2 2023: 12%Q3 2023: 12%Q4 2023: 12%Q1 2024: 12%24Q2 2024: 12%Q3 2024: 11%Q4 2024: 10%Q1 2025: 11%25Q2 2025: 12%Q3 2025: 11%Q4 2025: 12%Q1 2026: 11%26Q2 2026: 12%
  • Q2 2013: 11%
  • Q3 2013: 11%
  • Q4 2013: 11%
  • Q1 2014: 13%
  • Q2 2014: 14%
  • Q3 2014: 13%
  • Q4 2014: 11%
  • Q1 2015: 10%
  • Q2 2015: 10%
  • Q3 2015: 10%
  • Q4 2015: 9%
  • Q1 2016: 8%
  • Q2 2016: 8%
  • Q3 2016: 8%
  • Q4 2016: 7%
  • Q1 2017: 8%
  • Q2 2017: 9%
  • Q3 2017: 9%
  • Q4 2017: 8%
  • Q1 2018: 9%
  • Q2 2018: 9%
  • Q3 2018: 10%
  • Q4 2018: 9%
  • Q1 2019: 9%
  • Q2 2019: 9%
  • Q3 2019: 11%
  • Q4 2019: 13%
  • Q1 2020: 15%
  • Q2 2020: 14%
  • Q3 2020: 15%
  • Q4 2020: 13%
  • Q1 2021: 10%
  • Q2 2021: 12%
  • Q3 2021: 12%
  • Q4 2021: 12%
  • Q1 2022: 12%
  • Q2 2022: 11%
  • Q3 2022: 11%
  • Q4 2022: 11%
  • Q1 2023: 11%
  • Q2 2023: 12%
  • Q3 2023: 12%
  • Q4 2023: 12%
  • Q1 2024: 12%
  • Q2 2024: 12%
  • Q3 2024: 11%
  • Q4 2024: 10%
  • Q1 2025: 11%
  • Q2 2025: 12%
  • Q3 2025: 11%
  • Q4 2025: 12%
  • Q1 2026: 11%
  • Q2 2026: 12%

The positions that defined it

Every position that was ever among the 25 largest: when it first appeared, when it was largest, and where it stands in Q2 2026. The line is its reported value each quarter.

PositionValue over timeFirst listedLargestQ2 2026
Nvidia Corp(NVDA)Q2 2013$1.4bnQ2 2026$1.4bn
Facebook Inc(META)Class AQ3 2013$1.3bnQ2 2023$1.1bn
Intel Corp(INTC)Q2 2013$1.0bnQ2 2026$1.0bn
United Therapeutics Corp Del(UTHR)Q2 2013$1.1bnQ1 2026$926m
Palantir Technologies Inc(PLTR)Class AQ3 2021$1.8bnQ2 2025$883m
Alphabet Inc(GOOGL)Capital Stock Class AQ1 2016$828mQ2 2026$828m
Exelixis Inc(EXEL)Q2 2017$731mQ2 2026$731m
Verisign Inc(VRSN)Q2 2013$1.6bnQ2 2019$616m
Kinross Gold Corp(KGC)Q1 2019$780mQ1 2026$585m
Crowdstrike HLDGS Inc(CRWD)Class AQ2 2020$572mQ2 2026$572m
Sterling Construction Co Inc(STRL)Q1 2021$564mQ2 2026$564m
Alphabet Inc(GOOG)Capital Stock Class CQ1 2016$557mQ2 2026$557m
Bristol Myers Squibb Co(BMY)Q2 2013$3.9bnQ4 2019Soldlast listed Q1 2026
Abbvie Inc(ABBV)Q2 2013$1.9bnQ2 2020Soldlast listed Q3 2025
Baidu Inc(BIDU)Sponsored ADR REP AQ4 2013$1.9bnQ4 2020Soldlast listed Q4 2024
Celgene CorpQ2 2013$1.5bnQ3 2019Soldlast listed Q3 2019
Biogen Idec Inc(BIIB)Q2 2013$1.4bnQ1 2020Soldlast listed Q1 2026
Palo Alto Networks Inc(PANW)Q1 2014$1.3bnQ4 2019Soldlast listed Q4 2025
Pinduoduo Inc(PDD)Sponsored ADSQ2 2019$1.3bnQ4 2020Soldlast listed Q1 2026
Allergan PLCQ4 2015$1.3bnQ1 2020Soldlast listed Q1 2020

Quarter by quarter

2026Q1Q2
2025Q1Q2Q3Q4
2024Q1Q2Q3Q4
2023Q1Q2Q3Q4
2022Q1Q2Q3Q4
2021Q1Q2Q3Q4
2020Q1Q2Q3Q4
2019Q1Q2Q3Q4
2018Q1Q2Q3Q4
2017Q1Q2Q3Q4
2016Q1Q2Q3Q4
2015Q1Q2Q3Q4
2014Q1Q2Q3Q4
2013Q2Q3Q4

Q4 2015: $45.9bn across 3,253 positions

Against Q3 2015: 542 new, 1,863 added to, 832 trimmed, 416 sold out, across all 3,253 positions.

Turnover about 26% of the book, estimated from share changes at quarter-end prices.

Largest additions

  • Gilead Sciences Inc (GILD)+$207m
  • Palo Alto Networks Inc (PANW)+$131m
  • Cablevision Sys Corp+$124m
  • Novartis A G (NVS)+$111m
  • Cisco Sys Inc (CSCO)+$98m
  • Air Prods & Chems Inc (APD)+$95m
  • Juniper Networks Inc+$87m
  • Partnerre LTD+$87m

Largest reductions

  • Mead Johnson Nutrition Co-$206m
  • Chipotle Mexican Grill Inc (CMG)-$199m
  • Amgen Inc (AMGN)-$193m
  • Teva Pharmaceutical Inds LTD (TEVA)-$128m
  • Abbvie Inc (ABBV)-$125m
  • Visa Inc (V)-$88m
  • AT&T Inc (T)-$87m
  • Bed Bath & Beyond Inc-$86m

Opened

  • Apple Inc (AAPL)$470m
  • Ryanair HLDGS PLC (RYAAY)$308m
  • Pfizer Inc (PFE)$258m
  • Facebook Inc (META)$188m

Sold out

  • Sigma Aldrich Corpwas $330m
  • Ryanair HLDGS PLCwas $261m
  • Google Incwas $172m
  • Google Incwas $164m
  • Fedex Corp (FDX)was $135m
  • Cyberonics Incwas $129m
  • Alexion Pharmaceuticals Incwas $108m
  • Mckesson Corp (MCK)was $99m

Largest positions, Q4 2015

The largest 25 of 3,253 reported positions; the largest 500 carry 70.1% of the reported value.

PositionValueWeightOn the quarter
Novo-nordisk A S (NVO)$749m1.6%Trimmed
Colgate Palmolive Co (CL)$670m1.5%Trimmed
Apple Inc (AAPL)$470m1.0%New
Verisign Inc (VRSN)$426m0.9%Trimmed
Alaska Air Group Inc (ALK)$386m0.8%Trimmed
Netease Inc (NTES)$362m0.8%Trimmed
Linear Technology Corp$326m0.7%Added
Ryanair HLDGS PLC (RYAAY)$308m0.7%New
Mastercard Inc (MA)$294m0.6%Added
Dominos Pizza Inc (DPZ)$294m0.6%Trimmed
Cboe HLDGS Inc (CBOE)$286m0.6%Added
Novartis A G (NVS)$266m0.6%Added
Pfizer Inc (PFE)$258m0.6%New
Palo Alto Networks Inc (PANW)$239m0.5%Added
Gilead Sciences Inc (GILD)$235m0.5%Added
Duke Energy Corp New (DUK)$229m0.5%Added
Coca Cola Co (KO)$217m0.5%Added
Allegiant Travel Co (ALGT)$212m0.5%Added
Avalonbay Cmntys Inc (AVB)$210m0.5%Added
Bard C R Inc$208m0.5%Added
Hershey Co (HSY)$198m0.4%Trimmed
Barrick Gold Corp$190m0.4%Added
Huntington Ingalls Inds Inc (HII)$189m0.4%Added
Facebook Inc (META)$188m0.4%New
Clorox Co Del (CLX)$187m0.4%Trimmed

The books most like this one

Among the managers whose filings are on file, at Q2 2026. Overlap is the share of the two books that is the same: for every stock both list, the smaller of its two weights, added up. Two books can overlap because both own the largest companies; it says nothing about whether the managers agree.

ManagerOverlapStocks in bothOverlap over time
AQR Capital Management LLCat least 26%191Compare
Invesco Ltdat least 25%175Compare
Voloridge Investment Management LLCat least 24%174Compare
Arrowstreet Capital LPat least 24%187Compare
Acadian Asset Management LLCat least 23%169Compare
D. E. Shaw & Co.at least 23%146Compare
Man Group PLCat least 23%163Compare
Two Sigma Investments LPat least 23%178Compare

“At least” where either manager has more positions than are read each quarter: a stock both hold below that range is not counted.

The filings behind it

Every quarter above is one 13F holdings report, with any amendment the filer made to it applied in the order it was filed. Where the reporting entity changed, each quarter keeps the filer that actually reported it.

QuarterFilerBookAmendedFiling
Q2 2026Renaissance Technologies LLC$72.6bn13F-HR
Q1 2026Renaissance Technologies LLC$63.9bn13F-HR
Q4 2025Renaissance Technologies LLC$64.5bn13F-HR
Q3 2025Renaissance Technologies LLC$75.8bn13F-HR
Q2 2025Renaissance Technologies LLC$75.2bn13F-HR
Q1 2025Renaissance Technologies LLC$66.1bn13F-HR
Q4 2024Renaissance Technologies LLC$67.6bn13F-HR
Q3 2024Renaissance Technologies LLC$66.5bn13F-HR
Q2 2024Renaissance Technologies LLC$59.0bn13F-HR
Q1 2024Renaissance Technologies LLC$63.6bn13F-HR
Q4 2023Renaissance Technologies LLC$64.6bn13F-HR
Q3 2023Renaissance Technologies LLC$58.7bn13F-HR
Q2 2023Renaissance Technologies LLC$69.4bn13F-HR
Q1 2023Renaissance Technologies LLC$75.4bn13F-HR
Q4 2022Renaissance Technologies LLC$73.1bn13F-HR
Q3 2022Renaissance Technologies LLC$70.7bn13F-HR
Q2 2022Renaissance Technologies LLC$84.5bn13F-HR
Q1 2022Renaissance Technologies LLC$85.2bn13F-HR
Q4 2021Renaissance Technologies LLC$80.4bn13F-HR
Q3 2021Renaissance Technologies LLC$77.4bn13F-HR
Q2 2021Renaissance Technologies LLC$80.1bn13F-HR
Q1 2021Renaissance Technologies LLC$80.4bn13F-HR
Q4 2020Renaissance Technologies LLC$92.1bn13F-HR
Q3 2020Renaissance Technologies LLC$100bn13F-HR
Q2 2020Renaissance Technologies LLC$116bn13F-HR
Q1 2020Renaissance Technologies LLC$103bn13F-HR
Q4 2019Renaissance Technologies LLC$130bn13F-HR
Q3 2019Renaissance Technologies LLC$118bn13F-HR
Q2 2019Renaissance Technologies LLC$114bn13F-HR
Q1 2019Renaissance Technologies LLC$110bn13F-HR
Q4 2018Renaissance Technologies LLC$91.3bn13F-HR
Q3 2018Renaissance Technologies LLC$97.3bn13F-HR
Q2 2018Renaissance Technologies LLC$91.7bn13F-HR
Q1 2018Renaissance Technologies LLC$91.4bn13F-HR
Q4 2017Renaissance Technologies LLC$90.7bn13F-HR
Q3 2017Renaissance Technologies LLC$85.0bn13F-HR
Q2 2017Renaissance Technologies LLC$78.4bn13F-HR
Q1 2017Renaissance Technologies LLC$71.6bn13F-HR
Q4 2016Renaissance Technologies LLC$63.2bn13F-HR
Q3 2016Renaissance Technologies LLC$56.6bn13F-HR
Q2 2016Renaissance Technologies LLC$52.5bn13F-HR
Q1 2016Renaissance Technologies LLC$52.6bn13F-HR
Q4 2015Renaissance Technologies LLC$45.9bn13F-HR
Q3 2015Renaissance Technologies LLC$41.9bn13F-HR
Q2 2015Renaissance Technologies LLC$43.9bn13F-HR
Q1 2015Renaissance Technologies LLC$47.0bn13F-HR
Q4 2014Renaissance Technologies LLC$41.4bn13F-HR
Q3 2014Renaissance Technologies LLC$36.5bn13F-HR
Q2 2014Renaissance Technologies LLC$42.9bn13F-HR
Q1 2014Renaissance Technologies LLC$41.7bn13F-HR
Q4 2013Renaissance Technologies LLC$41.8bn13F-HR
Q3 2013Renaissance Technologies LLC$41.2bn13F-HR
Q2 2013Renaissance Technologies LLC$38.1bn13F-HR

Reading this record

A 13F lists US-listed long equity and options at the quarter end, filed up to 45 days later. It shows what was held, not when it was bought or at what price, and nothing short. Where a quarter lists only the largest positions, a name missing from it may still be held below that range; the counts of what was opened and sold always cover the whole filing.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More